Predicting Alzheimer dementia in mild cognitive impairment patients: Are biomarkers useful?
- 1 September 2006
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 545 (1), 73-80
- https://doi.org/10.1016/j.ejphar.2006.06.023
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Amino-Truncated β-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive ImpairmentClinical Chemistry, 2005
- Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairmentMolecular Psychiatry, 2003
- Amyloidosis and Alzheimer’s diseaseAdvanced Drug Delivery Reviews, 2002
- Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein formsNeurological Sciences, 2002
- Cerebrospinal Fluid Amyloid β1–42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's DiseaseExperimental Neurology, 2001
- Glutamate uptake is decreased in platelets from Alzheimer's disease patientsAnnals of Neurology, 2000
- Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasmaAmyloid, 2000
- Abnormal Hair Samples From Patients With Alzheimer DiseaseArchives of Dermatology, 1998
- Decreased Peripheral Glucocorticoid Sensitivity in Alzheimer’s DiseaseGerontology, 1993
- Platelet Coagulation Factor XI a -Inhibitor, a Form of Alzheimer Amyloid Precursor ProteinScience, 1990